186 related articles for article (PubMed ID: 22332018)
1. Multidrug resistance in breast cancer: from in vitro models to clinical studies.
Wind NS; Holen I
Int J Breast Cancer; 2011; 2011():967419. PubMed ID: 22332018
[TBL] [Abstract][Full Text] [Related]
2. Molecular Investigation of the Antitumor Effects of Monoamine Oxidase Inhibitors in Breast Cancer Cells.
Alkhawaldeh A; Bardaweel S
Biomed Res Int; 2023; 2023():2592691. PubMed ID: 37841082
[TBL] [Abstract][Full Text] [Related]
3.
Ozcan G
Front Oncol; 2023; 13():1216438. PubMed ID: 37700842
[TBL] [Abstract][Full Text] [Related]
4. Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study.
Sabet Z; Vagiannis D; Budagaga Y; Zhang Y; Novotná E; Hanke I; Rozkoš T; Hofman J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430819
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a prognostic risk model based on caveolin family genes for breast
Tang Q; Wang S; Di Z; Li H; Xu K; Hu X; Di M
Front Cell Dev Biol; 2022; 10():822187. PubMed ID: 36147736
[No Abstract] [Full Text] [Related]
6. DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease.
Tsyganov MM; Ibragimova MK; Gaptulbarova KA; Tsydenova IA; Dolgasheva DS; Garbukov EY; Frolova AA; Slonimskaya EM; Litvyakov NV
Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631534
[TBL] [Abstract][Full Text] [Related]
7. Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancer.
Ponnusamy L; Mahalingaiah PKS; Chang YW; Singh KP
Cancer Drug Resist; 2019; 2(2):297-312. PubMed ID: 35582717
[TBL] [Abstract][Full Text] [Related]
8. 'Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics'.
Mehmood S; Faheem M; Ismail H; Farhat SM; Ali M; Younis S; Asghar MN
Front Mol Biosci; 2022; 9():783494. PubMed ID: 35495618
[TBL] [Abstract][Full Text] [Related]
9. Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review.
Balma M; Liberini V; Racca M; Laudicella R; Bauckneht M; Buschiazzo A; Nicolotti DG; Peano S; Bianchi A; Albano G; Quartuccio N; Abgral R; Morbelli SD; D'Alessandria C; Terreno E; Huellner MW; Papaleo A; Deandreis D
Front Med (Lausanne); 2022; 9():881551. PubMed ID: 35492341
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells.
Wawruszak A; Luszczki J; Czerwonka A; Okon E; Stepulak A
Cells; 2022 Apr; 11(7):. PubMed ID: 35406775
[TBL] [Abstract][Full Text] [Related]
11. Curcumin as an Enhancer of Therapeutic Efficiency of Chemotherapy Drugs in Breast Cancer.
Farghadani R; Naidu R
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216255
[TBL] [Abstract][Full Text] [Related]
12. High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer.
Flörkemeier I; Steinhauer TN; Hedemann N; Weimer JP; Rogmans C; van Mackelenbergh MT; Maass N; Clement B; Bauerschlag DO
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008166
[TBL] [Abstract][Full Text] [Related]
13. Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges.
Rizwanullah M; Ahmad MZ; Ghoneim MM; Alshehri S; Imam SS; Md S; Alhakamy NA; Jain K; Ahmad J
Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959321
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic Consequences of
Pishas KI; Cowley KJ; Pandey A; Hoang T; Beach JA; Luu J; Vary R; Smith LK; Shembrey CE; Rashoo N; White MO; Simpson KJ; Bild A; Griffiths JI; Cheasley D; Campbell I; Bowtell DDL; Christie EL
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830797
[TBL] [Abstract][Full Text] [Related]
15. The Role of Genetic Pathways in the Development of Chemoradiation Resistance in Nasopharyngeal Carcinoma (NPC) Patients.
Mat Lazim N; Che Lah CI; Wan Juhari WK; Sulong S; Zilfalil BA; Abdullah B
Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828441
[TBL] [Abstract][Full Text] [Related]
16. Delivery Capacity and Anticancer Ability of the Berberine-Loaded Gold Nanoparticles to Promote the Apoptosis Effect in Breast Cancer.
Chiu CF; Fu RH; Hsu SH; Yu YA; Yang SF; Tsao TC; Chang KB; Yeh CA; Tang CM; Huang SC; Hung HS
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771481
[TBL] [Abstract][Full Text] [Related]
17. Injectable Composite Systems Based on Microparticles in Hydrogels for Bioactive Cargo Controlled Delivery.
Carrêlo H; Soares PIP; Borges JP; Cidade MT
Gels; 2021 Sep; 7(3):. PubMed ID: 34563033
[TBL] [Abstract][Full Text] [Related]
18. Ceramide expression in relation to breast cancer molecular subtypes in Saudi women.
Almomen A; Arafah M; Alwhaibi M; Alsaigh N; Alshememry A; Alsaleh NB; Alrabeeah D; Al Saleh K; Alshamsan A; Alkholief M
Saudi Pharm J; 2021 Jun; 29(6):609-615. PubMed ID: 34194268
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic Roles of ABC Transporters in Breast Cancer.
He J; Fortunati E; Liu DX; Li Y
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801148
[TBL] [Abstract][Full Text] [Related]
20. Matrix degradation and cell proliferation are coupled to promote invasion and escape from an engineered human breast microtumor.
Rabie EM; Zhang SX; Kourouklis AP; Kilinc AN; Simi AK; Radisky DC; Tien J; Nelson CM
Integr Biol (Camb); 2021 Feb; 13(1):17-29. PubMed ID: 33497442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
